Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents

Author： Roque Raquel   Ramiro Sofia   Cordeiro Ana   Gonçalves Pedro   Canas Silva   Santos Maria  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.30, Iss.6, 2011-06, pp. : 869-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis

By Wiland Piotr   Wojtala Renata   Goodacre John   Szechinski Jacek  

Clinical Rheumatology, Vol. 23, Iss. 3, 2004-06 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

TNF- −308 promoter polymorphism in patients with rheumatoid arthritis

By Pawlik A.   Florczak M.   Ostanek L.   Brzosko M.   Brzosko I.   Szklarz B. Gawronska  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 1, 2005-02 ,pp. : 22-26

Informa Healthcare

Access to resources Recommend Favorite

Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: what is the risk?

By Wendling Daniel  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1396-1397

Springer Publishing Company

Access to resources Recommend Favorite

Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis

By Kuroda Takeshi   Tanabe Naohito   Harada Takashi   Murakami Syuichi   Hasegawa Hisashi   Sakatsume Minoru   Nakano Masaaki   Gejyo Fumitake  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 498-505

Springer Publishing Company

Access to resources Recommend Favorite

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

By van Hoogmoed D   Fransen J   Repping-Wuts H   Spee L   Bleijenberg G   van Riel PLCM  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite